Framing Access to Medicines
Contemporary questions over access to medicines are speeding up as quickly as the advance of science. New drugs for a range of diseases are extending life and transforming health systems, with breakthroughs especially affecting the global South just in the past few years. The IP regime is also expanding and there are genuine questions around what a 21st century response looks like. How do we frame a pro-public health, pro-access, pro-innovation agenda? What alternatives to IP maximalism have a real chance of success? And how are academics and civil society responding?
...
